We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
92 hedge funds and large institutions have $87.7M invested in Invesco Pharmaceuticals ETF in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
14% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 14
2% more funds holding
Funds holding: 90 → 92 (+2)
2.05% less ownership
Funds ownership: 15.64% → 13.59% (-2%)
22% less capital invested
Capital invested by funds: $113M → $87.7M (-$25.3M)
47% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 32
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
92
Holders Change
+2
Holders Change %
+2.22%
% of All Funds
2.09%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
16
Increased
17
Reduced
32
Closed
14
Calls
$1M
Puts
–
Net Calls
+$1M
Net Calls Change
-$650K
Top Buyers
Top Sellers
| 1 |
TSS
Two Sigma Securities
New York
|
-$13.3M |
| 2 |
LPL Financial
San Diego,
California
|
-$2.51M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.32M |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$1.38M |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$1.38M |
